Search research articles
Contact Us
Filters
Showing results (61-70 of 284) with videos related to
Page
of 29
Sort By:
Practical Radiation Oncology
|
January 18, 2018
Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
Alejandro Gonzalez-Motta, Mack Roach
Oncology (Williston Park, N.Y.)
|
June 5, 2012
Radium-223: down to the bone, and less is more
Albert J Chang, Mack Roach
The New England Journal of Medicine
|
July 11, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivors
Jennifer S Yu, Mack Roach
Hematology/Oncology Clinics of North America
|
May 30, 2006
Radiotherapy in the management of common genitourinary malignancies
Joycelyn L Speight, Mack Roach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2007
Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy
Joycelyn L Speight, Mack Roach
The Journal of Urology
|
March 14, 2022
Editorial Comment
William S Chen, Mack Roach
European Urology
|
May 16, 2015
Postprostatectomy Radiotherapy for Patients with High-risk Features on Definitive Pathology: A Plea for Evidence-based Medicine
Alberto Bossi, Thomas Wiegel, Mack Roach
Cancer
|
June 23, 2009
Predictive models in external beam radiotherapy for clinically localized prostate cancer
Mack Roach, Fred Waldman, Alan Pollack
Vaccine
|
February 16, 2024
Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm
Steven Black, Mack Roach, Rino Rappuoli
CA: a Cancer Journal for Clinicians
|
March 12, 2005
Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond
M Kara Bucci, Alison Bevan, Mack Roach
Page
of 29
Search research articles
Search
Showing results (61-70 of 284) with videos related to
Sort By:
Page
of 29
Practical Radiation Oncology
|
January 18, 2018
Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
Alejandro Gonzalez-Motta, Mack Roach
Oncology (Williston Park, N.Y.)
|
June 5, 2012
Radium-223: down to the bone, and less is more
Albert J Chang, Mack Roach
The New England Journal of Medicine
|
July 11, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivors
Jennifer S Yu, Mack Roach
Hematology/Oncology Clinics of North America
|
May 30, 2006
Radiotherapy in the management of common genitourinary malignancies
Joycelyn L Speight, Mack Roach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2007
Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy
Joycelyn L Speight, Mack Roach
The Journal of Urology
|
March 14, 2022
Editorial Comment
William S Chen, Mack Roach
European Urology
|
May 16, 2015
Postprostatectomy Radiotherapy for Patients with High-risk Features on Definitive Pathology: A Plea for Evidence-based Medicine
Alberto Bossi, Thomas Wiegel, Mack Roach
Cancer
|
June 23, 2009
Predictive models in external beam radiotherapy for clinically localized prostate cancer
Mack Roach, Fred Waldman, Alan Pollack
Vaccine
|
February 16, 2024
Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm
Steven Black, Mack Roach, Rino Rappuoli
CA: a Cancer Journal for Clinicians
|
March 12, 2005
Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond
M Kara Bucci, Alison Bevan, Mack Roach
Page
of 29